Unlock instant, AI-driven research and patent intelligence for your innovation.
A pharmaceutical composition for dehydrating, shrinking and eliminating diseased tissue
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and medicine technology, applied in the field of diversion invention, can solve the problems of dehydration, shedding, atrophy and the like of diseased tissue, and achieve the effects of low price, convenient use and remarkable curative effect
Active Publication Date: 2016-06-01
谭国梁 +2
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] Although the above-mentioned substances are known as flocculants, so far, in the medical field, no one has used these properties to dehydrate, shrink, and even shed diseased tissues in living bodies.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0032] Embodiment 1: Get 10 grams of polyferric sulfate and 90 grams of distilled water to dissolve, pack in aseptic ampoules, 3ml / ampoules, vacuumize, and melt seal. When applied, dilute it with 1.5% levobupivacaine and 1.0% methylene blue injection to become 5% polyferric sulfate 0.75% levobupivacaine 0.5% methylene blue injection, and treat various diseases with appropriate dosage. Types of hemorrhoids, hemangiomas, varicose veins, hemorrhagic hematomas.
[0033] Operation procedure: clean and disinfect the affected area; draw an appropriate amount of injection, inject fractional points into hemorrhoids, hemangiomas, hematomas, and thrombus, and gently rub with cotton sticks to distribute evenly. Hemorrhoids, hemangiomas, and thrombus will harden in a few seconds; 1. The hemangioma becomes soft, dehydrated, shriveled, and disappears; the dehydration and atrophy process is completed within ten to twenty minutes; seven to fourteen days, the diseased tissue is replaced by norm...
Embodiment 2
[0034] Embodiment 2: Dissolve 7 grams of polyferric silicate sulfate (PFSS) and 93 grams of distilled water, pack in aseptic ampoules, 3ml / ampule, vacuumize, and melt seal. When applying, dilute it with 1.5% levobupivacaine 1.0% methylene blue injection to become 3.5% polysilicic acid ferric sulfate 0.75% levobupivacaine 0.5% methylene blue injection. Types of hemorrhoids, hemangiomas, varicose veins, hemorrhagic hematomas.
Embodiment 3
[0035] Example 3: Dissolve 7 grams of polyferric silicate (PFSC) and 93 grams of distilled water, pack in sterile ampoules, 3ml / ampule, vacuumize, and melt seal. When applied, dilute it with 1.5% levobupivacaine 1.0% methylene blue injection to become 3.5% polysilicon ferric chloride 0.75% levobupivacaine 0.5% methylene blue injection, with an appropriate dose, Treatment of various types of hemorrhoids, hemangioma, varicose veins, hemorrhagic hematoma.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a pharmaceutical composition capable of dehydrating, shrinking and eliminating diseased tissues, wherein the pharmaceutical composition has inorganic high molecular weight iron salt and / or inorganic high molecular weight iron salt complex as its active ingredient; The molecular iron salt can be polyferric sulfate (PFS), and the inorganic polymer iron salt complex can be selected from polymeric silicic acid complex iron salts, polymeric phosphate complex iron salts and / or their analogues. The diseased tissue is treated with the pharmaceutical composition of the invention to make it dehydrated, shrunk, absorbed or shed, thereby inhibiting the diseased tissue and achieving unexpected effects. The pharmaceutical composition of the present invention is low in price, remarkable in curative effect, convenient to use, and can effectively treat hemorrhoids, hemangiomas, varicose vessels, cysts, abscesses, tumors, water and fire burns, traumatic bleeding, local damage of microorganisms and chemical poisons, and the like.
Description
technical field [0001] The invention relates to a pharmaceutical composition for dehydrating, shrinking and eliminating diseased tissues in the field of medical innovation, and belongs to a diversion invention. Background technique [0002] Polymeric ferric sulfate (PFS) is basic ferric sulfate [ferricsubsulfate, molecular formula: Fe 4 (OH) 2 (SO4) 5 ] Polymer, referred to as Polyferric Sulfate (Polyferric Sulfate), the general chemical formula is [Fe 2 (OH) n (SO4) 3-0.5n ] m, wherein, 0.5<n<1, m=f(n). [0003] Traditionally, polyferric sulfate is an inorganic polymer iron salt flocculant. Compared with other various flocculants, it has the advantages of less dosage in the purification process, wide applicable pH range, high removal rate of impurities (turbidity, COD, suspended solids, etc.), low residue concentration, fast settling speed of alum flowers, and decolorization It is widely used in the purification treatment of industrial wastewater, urban sewage,...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
